Company news

Cosmos Health Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Cosmos Health Completes Acquisition of Pelofarm's Pharmacy Distribution Network; Annual Revenue Poised to Grow by Over $5 Million

June 12, 2024

Cosmos Health Successfully Completes Acquisition of Pharmatrade’s Assets; Expects to Increase FY 2024 Annual Revenue by over $5 Million

February 28, 2024

Cosmos Health Completes Acquisition of Cloudscreen, a Cutting-Edge AI Platform; Enters Lucrative $25Bn+ Global Drug Repurposing Market

January 22, 2024

Cosmos Health Bolsters Presence in $400Bn+ Global Generic Drugs Market with $3.5M Acquisition of 10-Drug Portfolio

January 17, 2024

Cosmos Health Enters into Definitive Agreement to Acquire Type-2 Diabetes Treatment DIABIT-IS X

December 19, 2023

Cosmos Health Announces Open Market Stock Purchases by the CEO

December 17, 2023

Cosmos Health Enters into Agreement to Acquire Rights for WIPO-Filed Patent on Drug Targeting CNS Cancers

December 6, 2023

Cosmos Health Announces Patent Filing for its Obesity and Weight Management Product

November 30, 2023

Cosmos Health Reports Q3 2023 Results; Revenue Increased 7% YoY, Total Assets Reached Record $71.5M with Stockholders' Equity of $44.2M or $3.4/Share

November 20, 2023

Cosmos Health to Acquire Cloudscreen, a Cutting-Edge AI-Powered Drug Repurposing Platform; Anticipated to Establish Cosmos as a Leader in the $25Bn Global Market and Deliver Unparalleled Returns for Shareholders

October 10, 2023

Cosmos Health Announces Strategic Collaboration with C.A.PAPAELLINAS Group

September 19, 2023

Cosmos Health Starts Stock Buyback Program

September 12, 2023

Cosmos Health Introduces Guidance; Expects to Achieve Over $180M in Gross Annual Revenue and EBITDA in Excess of $20M by 2026; Recaps Significant Events Reported So Far in 2023

September 11, 2023

Cosmos Health Reports Q2 2023 Financial Results; Adjusted Net Income Increases by 3550% to Surpass $3 Million for H1 2023 vs $(0.09) Million H1 2022; Book Value per Share Exceeds $4.04

August 14, 2023

Cosmos Health Appoints Big 4 Accounting Firm KPMG as Auditor

August 7, 2023

Cosmos Health Continues to Expand Mediterranation Brand, Welcomes Eleonas and Olympus Mons; Boosts Exports and Secures Purchase Orders, Including from Leading Multinational Health Food Chain

August 1, 2023

Cosmos Health Provides Update on Recent Developments, Maintains Strong Financial Position, Reaffirms Commitment to Growth, and Highlights CEO's Continued Investment Now Exceeds $15 Million

July 24, 2023

Cosmos Health Inc. Announces Pricing of $5.25 Million Registered Direct Offering and Concurrent Private Placement

July 19, 2023

Cosmos Health Successfully Completes Acquisition of Cana Laboratories; Anticipates to Record a Substantial Gain on Bargain Purchase

July 5, 2023

Cosmos Health Launches Chios Island, the Latest Addition to Its Mediterranation Premium Line of Supplements

June 28, 2023

Cosmos Health Successfully Closes Acquisition of Assets from I. Bikas GP; Annual Revenue Projected to Grow by over $10 Million

June 15, 2023

Cosmos Health Expands Premium Nutritional Supplements Line Mediterranation with the Launch of Terra Creta

June 12, 2023

Cosmos Health set to join Russell Microcap Index

May 30, 2023

Cosmos Health Enters into Binding Letter of Intent for the Acquisition of Docpharm GmbH., an Established German Pharmaceutical Distributor; Expected to Boost Our Annual Revenue by Approximately €32M, or 70%, by the End of 2025 vs FY 2022.

May 24, 2023

Cosmos Health Reports First Quarter 2023 Financial Results; Delivers Positive Adjusted EBITDA and Significant Increase in Adjusted Net Income

May 16, 2023

Cosmos Health Enters Final Phase for the Acquisition of Cana Laboratories Following Conclusion of Stock Purchase Agreement

May 7, 2023

Cosmos Health Advances Its Strategic Plan; Acquires Distressed Property Housing Operations of CosmoFarm, Expected to Generate Substantial Value for Shareholders

May 2, 2023

Cosmos Health Ends 2022 with Transformed Balance Sheet and Achieves Positive Adjusted EBITDA for the Fiscal Year 2022

April 12, 2023

Cosmos Health Inc. Enters U.S. Telehealth Space with Successful Acquisition of ZipDoctor, Inc.

April 2, 2023

Cosmos Health Inc. Enters into a Definitive Agreement to Acquire ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp.

March 16, 2023

Cosmos Health Enters into a Material Definitive Agreement with Cana Laboratories

March 6, 2023

Cosmos Health Expects to Acquire ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp.

March 2, 2023

Cosmos Health Extends its Agreement to Acquire ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp.

February 14, 2023

Cosmos Health Announces Initial Purchase Order with Virax Biolabs for the Distribution of COVID-19 and Influenza A+B Antigen Combo Rapid Tests

February 6, 2023

Cosmos Health Announces Application for Dual Listing on Upstream

February 1, 2023

Cosmos Health Announces the Appointment of Nikos Bardakis, an Experienced Executive in the Pharmaceutical Industry, as Chief Operating Officer

January 31, 2023

Cosmos Health Retains Christian Levine Law Group to Further Monitor Trading Irregularities

January 25, 2023

Cosmos Health Announces Stock Buyback Program

January 23, 2023

Cosmos Health Extends and Updates its Agreement to Acquire ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp

January 19, 2023

Cosmos Health Provides an Update on its Debt Balance and Proforma Interest Expense

January 16, 2023

Cosmos Health Extends and Updates its Agreement to Acquire Cana Laboratories, a European Pharmaceutical Company

January 9, 2023

Cosmos Health Regains Nasdaq Minimum Bid Price Compliance

January 4, 2023

Cosmos Health Inc. Announces Successful Closing of $32.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market

December 20, 2022

Cosmos Health Inc. Announces Pricing of $32.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market

December 18, 2022

Cosmos Holdings Inc. Changes its Name to Cosmos Health Inc. and Announces a 1-For-25 Reverse Stock Split

December 14, 2022

Cosmos Health Retains Shareholder Intelligence Services, LLC

December 8, 2022

Cosmos Health Enters the Development Phase for CCX0722, an Innovative Product for Obesity and Weight Management

November 28, 2022

Cosmos Health to Sell its Sky Premium Life Luxury Food Supplement Brand on Iberian Airlines' In-flight Magazine, Ronda.

November 20, 2022

Cosmos Health Reports Third Quarter 2022 Financial Results

November 14, 2022

Cosmos Health Obtains Exclusive Rights to Market and Distribute Nickelodeon's SpongeBob and PAW Patrol Kids' Vitamins in Greece and Cyprus

November 13, 2022

← Newer news releases · Older news releases →

Decks